Medical Developments International Ltd MVP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.53
- Day Range
- A$0.50–0.53
- 52-Week Range
- A$0.50–1.80
- Bid/Ask
- A$0.50 / A$0.50
- Market Cap
- A$43.15 Mil
- Volume/Avg
- 121,366 / 183,287
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.37
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Medical Developments International Ltd is a specialized healthcare company. It manufactures and distributes the pharmaceutical drug and medical and veterinary equipment. The company provides a range of products in the areas of pain management, asthma, and resuscitation, plus veterinary equipment. It is organized into three business units: Pharmaceuticals, Medical Devices, and Veterinary products. Majority of its revenue comes from Pharmaceuticals Unit which engages in the sale of Penthrox within Australia, New Zealand, Europe the UK and some sales in Canada, the Middle East, Asia and South Africa.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 68
- Website
- https://www.medicaldev.com
Comparables
Valuation
|
Metric
|
MVP
|
PHN
|
JULPHAR
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 33.04 | — |
Price/Book Value | 0.60 | 9.35 | 1.37 |
Price/Sales | 1.37 | 5.06 | 0.66 |
Price/Cash Flow | — | 30.41 | 8.93 |
Price/Earnings
MVP
PHN
JULPHAR
Financial Strength
|
Metric
|
MVP
|
PHN
|
JULPHAR
|
|---|---|---|---|
Quick Ratio | 1.84 | 1.77 | 1.18 |
Current Ratio | 2.78 | 2.12 | 2.26 |
Interest Coverage | −271.40 | 29.60 | −0.51 |
Quick Ratio
MVP
PHN
JULPHAR
Profitability
|
Metric
|
MVP
|
PHN
|
JULPHAR
|
|---|---|---|---|
Return on Assets (Normalized) | −18.67% | 0.01% | −4.07% |
Return on Equity (Normalized) | −22.93% | 0.03% | −11.76% |
Return on Invested Capital (Normalized) | −22.84% | 0.51% | −2.25% |
Return on Assets
MVP
PHN
JULPHAR
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Dqskbbtbf | Pbjp | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Hfnmdsczs | Hrxpp | $70.8 Bil | |
HLN
| Haleon PLC ADR | Bthdshtw | Dpj | $38.2 Bil | |
VTRS
| Viatris Inc | Njspgbzs | Gznb | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Wjqlzmjvc | Kzqxp | $12.5 Bil | |
CTLT
| Catalent Inc | Nvcxnrcjr | Vgzxkk | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Pmkhmyr | Wvsl | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Vdxcnnvvf | Jsl | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Fhkdzmc | Qlvld | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Gkdkxcvfj | Fcx | $2.9 Bil |